SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Quantum Computing, Inc. engages in developing novel algorithms and solutions utilizing quantum and quantum-inspired computing to solve difficult problems in various industries. It leverages its expertise in finance, computing, security, mathematics, and physics to develop commercial applications for the financial, security, and government sectors. The company was founded on July 25, 2001 and is headquartered in Hoboken, NJ.

Quantum Computing Inc

Quantum Computing Inc. (QUBT) is facing significant downward pressure and intense community debate as investors react to its recent financial performance, high short interest, and ongoing concerns about dilution. While proponents highlight the company's room-temperature photonics technology and potential for future contracts, skeptics are actively targeting the stock, citing poor revenue growth relative to spending and a broader slump across the quantum sector.

Eastman Kodak Co. engages in the provision of analog and digital innovations. It operates through the following segments: Traditional Printing, Digital Printing, Advanced Materials and Chemicals, and Brand. The Traditional Printing segment consists of Prepress Solutions, which includes Kodak's digital offset plate offerings and computer-to-plate imaging solutions. The Digital Printing segment contains Electrophotographic Printing Solutions, Prosper, Versamark and Software. The Advanced Materials and Chemicals segment consists of four lines of business: Industrial Film and Chemicals, Motion Picture, Advanced Materials and Functional Printing, and Kodak Services for Business (KSB). The Brand segment includes licensing of the Kodak brand to third parties. The company was founded by George Eastman in 1880 and is headquartered in Rochester, NY.

Eastman Kodak Co.

Eastman Kodak is generating significant buzz as investors track potential pharmaceutical manufacturing contracts and speculation around onshoring drug production, coupled with optimism regarding their latest earnings performance. Community sentiment remains highly split, with bulls pointing to the company's industrial pivot and valuation as a long-term play, while others remain skeptical of the stock's tendency for hype-driven volatility.

Nokia Oyj engages in the provision of network infrastructure, technology, and software services. It operates through the following segments: Mobile Networks, Network Infrastructure, Cloud and Network Services, and Nokia Technologies. The Mobile Networks segment offers technologies for Radio Access Networks (RAN) as well as Microwave Radio Links (MWR) for transport networks. The Network Infrastructure serves communication service providers, enterprises, webscales and public sector customers. The Cloud and Network Services segment builds around software and the cloud and is focused on driving leadership in cloud-native software and as-a-service delivery models, as demand for critical networks accelerates; and with strong market positions in communications software, private wireless networks, and cognitive (or intelligent) services. The Nokia Technologies segment, building on decades of innovation and R&D leadership in technologies used in virtually all mobile devices used today, is expanding the Nokia patent licensing business, reintroducing the Nokia brand to smartphones through brand licensing, and establishing a technology licensing business. The company was founded by Fredrik Idestam in 1865 and is headquartered in Espoo, Finland.

Nokia Corp - ADR

Nokia Corp

Nokia is trending as investors digest a surge in institutional buying and a series of strategic partnerships in AI infrastructure and telecommunications. The community is actively discussing the stock's long-term potential as a 'sleeping giant,' with many traders highlighting its pivot from legacy hardware to a critical player in the AI supercycle and network innovation.

Replimune Group, Inc. is a clinical-stage biotechnology company. It engages in the business of developing oncolytic immunotherapies for the treatment of cancer. The company was founded by Philip Astley-Sparke, Colin A. Love, and Robert Coffin in March 2015 and is headquartered in Woburn, MA.

Replimune Group Inc

Replimune Group is trending as investors monitor the company's progress toward a high-stakes April 10 PDUFA date for its skin cancer drug. Community discussion is heavily split between optimism for an approval based on recent FDA resubmission progress and skepticism regarding the potential for another Complete Response Letter, with many traders closely watching options activity and institutional positioning as a binary catalyst approaches.

Aehr Test Systems engages in the design, manufacture, market, and sale of test and burn-in equipment used in the semiconductor industry. Its products include FOX-XP, FOX-NP, and FOX-CP wafer contact parallel test and burn-in systems, the WaferPak full wafer contactor, the DiePak Carrier, the WaferPak Aligner, the DiePak Autoloader, and test fixtures. The company was founded by Rhea J. Posedel on May 25, 1977 and is headquartered in Fremont, CA.

Aehr Test Systems

Aehr Test Systems is surging as investors closely monitor the upcoming earnings report and anticipate news regarding potential high-volume production orders from major hyperscale customers. The community is actively debating the company's ability to capitalize on AI infrastructure expansion, with many focused on whether recent technological validations will finally transition into sustained, scalable revenue growth.

MATH is a one stop crypto solution platform which contains MathWallet, MATH VPOS Pool, MathDEX, MATH dApp Store, MATH Staking, MATH Pay, MATH Chain, etc.

MATH

MATH is seeing heightened interest as investors speculate on potential breakout momentum, with discussions heavily focused on historical pump-and-dump patterns and its status as a low-cap asset. While some community members remain optimistic about significant upside targets linked to broader market rotations, others are expressing frustration over stagnant performance and questioning the leadership.

Tesla, Inc. engages in the design, development, manufacture, and sale of electric vehicles and energy generation and storage systems. It operates through the Automotive and Energy Generation and Storage segments. The Automotive segment includes the design, development, manufacture, sale, and lease of electric vehicles as well as sales of automotive regulatory credits. The Energy Generation and Storage segment is involved in the design, manufacture, installation, sale, and lease of solar energy generation, energy storage products, and related services and sales of solar energy systems incentives. The company was founded by Jeffrey B. Straubel, Elon Reeve Musk, Martin Eberhard, and Marc Tarpenning on July 1, 2003 and is headquartered in Austin, TX.

Tesla Inc

Tesla is currently facing significant volatility as investors digest underwhelming delivery figures that fell short of expectations, fueling community debate over the company's long-term identity as an AI and robotics leader versus a struggling automaker. Many market participants are also monitoring speculation regarding a potential SpaceX IPO as a major catalyst that could either provide a pivot for Tesla's valuation or serve as a distraction for management.

Bitcoin Cash is a hard fork of Bitcoin with a protocol upgrade to fix on-chain capacity. Bitcoin Cash intends to be a Bitcoin without Segregated Witness (SegWit) as soft fork, where upgrades of the protocol are done mainly through hard forks and without changing the original economic rules of the Bitcoin.  Bitcoin Cash (BCH) is released on 1st August 2017 as an upgraded version of the original Bitcoin Core software. The main upgrade is the increase in the block size limit from 1MB to 8MB. This effectively allows miners on the BCH chain to process up to 8 times more payments per second in comparison to Bitcoin. This makes for faster, cheaper transactions and a much smoother user experience.  Why was Bitcoin Cash Created?  The main objective of Bitcoin Cash is to to bring back the essential qualities of money inherent in the original Bitcoin software. Over the years, these qualities were filtered out of Bitcoin Core and progress was stifled by various people, organizations, and companies involved in Bitcoin protocol development. The result is that Bitcoin Core is currently unusable as money due to increasingly high fees per transactions and transfer times taking hours to complete. This is all because of the 1MB limitation of Bitcoin Core’s block size, causing it unable to accommodate to large number of transactions.  Essentially Bitcoin Cash is a community-activated upgrade (otherwise known as a hard fork) of Bitcoin that increased the block size to 8MB, solving the scaling issues that plague Bitcoin Core today.  Nov 16th 2018: A hashwar resulted in a split between Bitcoin SV and Bitcoin ABC

Bitcoin Cash

Bitcoin Cash is capturing investor attention as it shows signs of decoupling from the broader crypto market, with community members actively discussing a potential breakout and analyzing the upcoming 'Layla' network upgrade. The discourse is heavily divided between bullish sentiment regarding its utility and long-term value, and skepticism from those who dismiss it as an underperforming asset compared to Bitcoin.

Fabrinet engages in the provision of optical packaging and electronic manufacturing services to original equipment manufacturers. The firm's engineering services include process design, failure analysis, reliability testing, tooling design, and real-time traceability system. Its manufacturing operations offer sensors, subsystems, customized optics, and optical modules and components. The company was founded by David Thomas Mitchell on August 12, 1999 and is headquartered in George Town, Cayman Islands.

Fabrinet

Fabrinet is currently trending as investors weigh its critical role in AI infrastructure, particularly as a key supplier for high-speed optical transceivers and datacom packaging. Community discussion centers on whether the stock's recent valuation and manufacturing growth can maintain momentum following its latest financial results, with many traders actively debating the merits of tactical entries during periods of high volatility.

Omeros Corp. operates as a biopharmaceutical company. The firm engages in the discovery, development, and commercializing of both small-molecule and protein therapeutics for large market. It also offers orphan indications targeting inflammation, coagulopathies, and disorders of the central nervous system. The company was founded by Gregory A. Demopulos and Pamela Pierce Palmer on June 16, 1994 and is headquartered in Seattle, WA.

Omeros Corporation

Omeros Corp

Omeros Corp is trending as investors monitor the early commercial rollout of its FDA-approved transplant therapy, YARTEMLEA, while speculating on potential buyout interest given the firm's strategic partnership with Novo Nordisk. Community discussion remains focused on the company's patent portfolio and the clinical significance of its drug pipeline, though sentiment is split between those betting on long-term growth and others frustrated by recent stock volatility.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Sera Prognostics (SERA) Upgraded to Buy: What Does It Mean for the Stock?

Sera Prognostics (SERA) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

5 Top-Ranked Stocks With Rising P/E That Investors Can Bet On

Tap five stocks with increasing P/E ratios to try out an out-of-the-box approach. These stocks are HRB, SPWH, SERA, VEEV and WKHS.

Sera Prognostics Q4 Earnings Call Highlights

Sera Prognostics (NASDAQ:SERA) executives emphasized progress in evidence generation and early commercialization efforts during the company's fourth-quarter and full-year 2025 earnings call, held...

Sera Prognostics Q4 2025 Earnings Call Transcript

@media (max-width: 768px) { .image-container { width: 100% !important; float: none !important; margin: 0 0 1rem 0 !important; } } Image source: The Mo...

Sera Prognostics, Inc. (SERA) Reports Q4 Loss, Lags Revenue Estimates

Sera Prognostics (SERA) delivered earnings and revenue surprises of +5.88% and -75.00%, respectively, for the quarter ended December 2025. Do the numbers hold clues to what lies ahead for the stock?

Sera Prognostics (NASDAQ:SERA) Releases Quarterly Earnings Results, Beats Expectations By $0.01 EPS

Sera Prognostics (NASDAQ:SERA - Get Free Report) announced its earnings results on Wednesday. The company reported ($0.16) EPS for the quarter, beating analysts' consensus estimates of ($0.17) by...

SERA PROGNOSTICS REPORTS FOURTH QUARTER AND FULL YEAR 2025 FINANCIAL RESULTS

SERA PROGNOSTICS REPORTS FOURTH QUARTER AND FULL YEAR 2025 FINANCIAL RESULTS SERA PROGNOSTICS REPORTS FOURTH QUARTER AND FULL YEAR 2025 FINANCIAL RESULTS PR Newswire SALT LAKE CITY, March 18, 2026...

Sera Prognostics (NASDAQ:SERA) CEO Zhenya Lindgardt Sells 22,639 Shares

Sera Prognostics, Inc. (NASDAQ:SERA - Get Free Report) CEO Zhenya Lindgardt sold 22,639 shares of the firm's stock in a transaction that occurred on Tuesday, March 10th. The shares were sold at an...

Sera Prognostics (NASDAQ:SERA) CEO Sells $43,014.10 in Stock

Sera Prognostics, Inc. (NASDAQ:SERA - Get Free Report) CEO Zhenya Lindgardt sold 22,639 shares of the stock in a transaction dated Tuesday, March 10th. The shares were sold at an average price of...

Austin Aerts Sells 6,069 Shares of Sera Prognostics (NASDAQ:SERA) Stock

Sera Prognostics, Inc. (NASDAQ:SERA - Get Free Report) CFO Austin Aerts sold 6,069 shares of the business's stock in a transaction on Tuesday, March 10th. The shares were sold at an average price of...

Sera Prognostics, Inc. engages in the provision of personalized diagnostics to predict and manage pregnancy complications. It focuses on developing blood tests to predict the risks of preterm birth, preeclampsia and other pregnancy complications. The company was founded by Steven W. Graves, Dennis Farrar and M. Sean Esplin in 2008 and is headquartered in Salt Lake City, UT.

Sera Prognostics Inc - Ordinary Shares Class A

Opendoor ($OPEN)

Strategy ($MSTR)

American Eagle ($AEO)

Ondas Inc. ($ONDS)

The stock that proved the power of the crowd. Fueled by community energy and social momentum, this winner captivated retail investors regardless of what the "experts" or traditional fundamentals had to say.

Current Price	$2.01
Prev Close	$2.07
Open	$2.03
Dividend Yield	0.00%
50-Day Moving Average	$2.33
Beta	0.80
Avg. Volume	98,484.57
PE Ratio	-2.98

52-Week High	$4.09
52-Week Low	$1.37
Market Capitalization	$81.03M
EPS (Annual)	-$0.6699
Price to Book	1.04
Revenue Per Employee	$1,125.00

SERA
Sera Prognostics Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest SERA News

SERASera Prognostics Inc